Last reviewed · How we verify

NCT06570616

Addressing Unintentional Leakage When Using Nasal CPAP - Study A

Recruiting now NA Last updated 30 April 2025
What this trial tests

NA trial testing CPAP (fixed mode) in Continuous Positive Airway Pressure in 100 participants. Currently enrolling.

Timeline
30 April 2025
Primary endpoint
31 December 2025
31 December 2028

Quick facts

Lead sponsorUniversity of Sao Paulo General Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposesupportive care
Enrollment100
Start date30 April 2025
Primary completion31 December 2025
Estimated completion31 December 2028
Sites2 locations across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

University of Sao Paulo General Hospital

Who can join

18 and older, any sex, with Continuous Positive Airway Pressure or Adverse Effect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Oral unintentional leak is a common side effect of continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA) treatment. Management of oral unintentional leakage has not been standardized and the effectiveness of potential approaches have not been studied in controlled studies. Higher levels of CPAP are associated with higher leak. In the present study, a sequential approach to control excessive unintentional leak will be tested. In study A, the reduction of therapeutic CPAP level will be tested. In study B, oronasal CPAP will be compared to nasal CPAP with a chinstrap.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Continuous Positive Airway Pressure

Currently open trials in the same condition.

Other University of Sao Paulo General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06570616.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing